We're having difficulty determining when it is appropriate to bill for a skin biopsy. Some of our clinicians believe they can bill a biopsy only when they use specific methods for removing the suspect lesion. I don't believe this is correct. Could you point me to some documentation that provides guidance?
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.